Yukio Kato

10.0k total citations · 1 hit paper
306 papers, 7.9k citations indexed

About

Yukio Kato is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Yukio Kato has authored 306 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 126 papers in Oncology, 88 papers in Molecular Biology and 44 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Yukio Kato's work include Drug Transport and Resistance Mechanisms (107 papers), Pharmacological Effects and Toxicity Studies (33 papers) and Metabolism and Genetic Disorders (31 papers). Yukio Kato is often cited by papers focused on Drug Transport and Resistance Mechanisms (107 papers), Pharmacological Effects and Toxicity Studies (33 papers) and Metabolism and Genetic Disorders (31 papers). Yukio Kato collaborates with scholars based in Japan, United States and France. Yukio Kato's co-authors include Yuichi Sugiyama, Kazunori Kataoka, Akira Tsuji, Noritaka Nakamichi, Yoshimichi Sai, Tomoko Sugiura, Yoshiyuki Kubo, Nobuhiro Nishiyama, Xiaoyan Chu and Yuichi Sugiyama and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Yukio Kato

296 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.

2003 515 citations Yukio Kato et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yukio Kato Japan	45	2.8k	2.4k	1.0k	902	847	306	7.9k
Gert Fricker Germany	56	4.2k 1.5×	3.3k 1.4×	1.9k 1.9×	767 0.9×	1.3k 1.5×	258	10.6k
Fuu‐Jen Tsai Taiwan	55	1.4k 0.5×	5.8k 2.4×	603 0.6×	650 0.7×	310 0.4×	520	13.9k
Dong Wang China	57	3.9k 1.4×	8.5k 3.6×	262 0.3×	445 0.5×	672 0.8×	548	15.9k
Xiaoyan Liu China	53	1.3k 0.5×	7.3k 3.0×	352 0.3×	368 0.4×	696 0.8×	691	14.3k
Martin Michaelis Germany	53	1.4k 0.5×	3.7k 1.6×	279 0.3×	651 0.7×	669 0.8×	232	9.8k
Akira Hara Japan	59	2.1k 0.7×	6.7k 2.8×	1.1k 1.1×	705 0.8×	123 0.1×	786	16.0k
Tetsuya Terasaki Japan	75	8.2k 3.0×	6.0k 2.5×	3.8k 3.7×	1.4k 1.5×	670 0.8×	406	19.4k
Fang Liu China	62	2.0k 0.7×	7.4k 3.1×	265 0.3×	484 0.5×	999 1.2×	571	14.9k
Peter Boor Germany	62	1.2k 0.4×	5.2k 2.2×	446 0.4×	345 0.4×	206 0.2×	449	14.7k
Marcel Leist Germany	77	1.5k 0.6×	10.1k 4.2×	672 0.7×	878 1.0×	194 0.2×	291	19.4k

Countries citing papers authored by Yukio Kato

Since Specialization

Citations

This map shows the geographic impact of Yukio Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukio Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukio Kato more than expected).

Fields of papers citing papers by Yukio Kato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukio Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukio Kato. The network helps show where Yukio Kato may publish in the future.

Co-authorship network of co-authors of Yukio Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Yukio Kato. A scholar is included among the top collaborators of Yukio Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukio Kato. Yukio Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nishioka, K., et al.. (2025). Estimation and Validation of an Effective Ergothioneine Dose for Improved Sleep Quality Using Physiologically Based Pharmacokinetic Model. Food Science & Nutrition. 13(6). e70382–e70382.

Nishioka, Kentaro, Takahiro Ishimoto, Yumi Nakamura, et al.. (2025). Optimizing oral 3-hydroxybutyrate dosage using pharmacokinetic model to improve cognitive function and mood in healthy subjects. Frontiers in Nutrition. 11. 1470331–1470331.

Wang, Huimin, Mathieu Danoy, Hiroshi Arakawa, et al.. (2024). Palmitic Acid Induced a Dedifferentiation Profile at the Transcriptome Level: A Collagen Synthesis but no Triglyceride Accumulation in Hepatocyte‐Like Cells Derived From Human‐Induced Pluripotent Stem Cells Cultivated Inside Organ on a Chip. Journal of Applied Toxicology. 45(3). 460–471. 2 indexed citations

Poulain, Stéphane, Masahiro Sugimoto, Hiroshi Arakawa, et al.. (2024). Mechanobiological stimulation in organ‐on‐a‐chip systems reduces hepatic drug metabolic capacity in favor of regenerative specialization. Biotechnology and Bioengineering. 121(4). 1434–1451. 1 indexed citations

Inamatsu, Mutsumi, Hiroshi Arakawa, Yukio Kato, et al.. (2024). Gut–liver microphysiological systems revealed potential crosstalk mechanism modulating drug metabolism. PNAS Nexus. 3(2). pgae070–pgae070. 8 indexed citations

Arakawa, Hiroshi, Takumi Nishiuchi, Makiko Meguro‐Horike, et al.. (2023). Renal Pharmacokinetic Adaptation to Cholestasis Causes Increased Nephrotoxic Drug Accumulation by Mrp6 Downregulation in Mice. Journal of Pharmaceutical Sciences. 112(12). 3209–3215. 1 indexed citations

Iida, Noriho, Eishiro Mizukoshi, Tatsuya Yamashita, et al.. (2021). Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis. Nature Cancer. 2(10). 1039–1054. 55 indexed citations

Yamada, Hiroyuki, S. Shibata, Eiko Matsumoto, et al.. (2020). Possible utility of peptide-transporter-targeting [19F]dipeptides for visualization of the biodistribution of cancers by nuclear magnetic resonance imaging. International Journal of Pharmaceutics. 586. 119575–119575. 3 indexed citations

Ishimoto, Takahiro & Yukio Kato. (2017). [Physiolgically-based pharmacokinetics:Theory and examples.]. PubMed. 26(11). 1529–1537. 2 indexed citations

10.

Kato, Yukio, et al.. (2007). A study on smooth blasting technique using detonating cords. 68(6). 167–171. 4 indexed citations

11.

Kondo, Jun, Fuyuki Sato, Katsumi Fujimoto, et al.. (2006). 57Arg in the bHLH transcription factor DEC2 is essential for the suppression of CLOCK/BMAL2-mediated transactivation. International Journal of Molecular Medicine. 17(6). 1053–6. 12 indexed citations

12.

Kato, Yukio, et al.. (2005). Specification and Assessment of Different Intersection Assistance Concepts Based on IVC (Inter-Vehicle-Communication) and RVC (Roadside-Vehicle-Communication). 6 indexed citations

13.

Kato, Yukio, et al.. (2004). Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population. Journal of Pharmaceutical Sciences. 93(12). 2920–2926. 22 indexed citations

14.

Kato, Yukio, et al.. (2004). Detonability of emulsion explosives precompressed by dynamic pressure. 65(3). 88–93. 1 indexed citations

15.

Kato, Yukio, et al.. (2003). Determination of JWL parameters from underwater explosion test for ideal and non-ideal explosives. 64(6). 248–253. 7 indexed citations

16.

Nakamura, Yuichi, Toru Hamada, Kenji Murata, Yukio Kato, & Shigeru Itoh. (2003). An investigation on under water sympathetic detonation for high explosives. 64(1). 46–51. 1 indexed citations

17.

Han, Yong–Hae, Yukio Kato, Masayuki Haramura, et al.. (2001). Physicochemical Parameters Responsible for the Affinity of Methotrexate Analogs for Rat Canalicular Multispecific Organic Anion Transporter (cMOAT/MRP2). Pharmaceutical Research. 18(5). 579–586. 16 indexed citations

18.

Gotoh, Yukiko, Hideo Suzuki, Satoshi Kinoshita, et al.. (2000). Involvement of an Organic Anion Transporter (Canalicular Multispecific Organic Anion Transporter/Multidrug Resistance-Associated Protein 2) in Gastrointestinal Secretion of Glutathione Conjugates in Rats. Journal of Pharmacology and Experimental Therapeutics. 292(1). 433–439. 126 indexed citations

19.

Yamagiwa, H, Naoaki Onishi, Toru Onishi, et al.. (1995). [Immunohistochemical study of PCNA, EGFR, c-erbB-2 and p53 in carcinomas of large intestine].. PubMed. 43(7). 703–7. 2 indexed citations

20.

Kobayashi, Masashi, Hiroaki Suzuki, Yukio Kato, et al.. (1978). [Hematological studies in patients with anorexia nervosa (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(6). 859–66. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact